Skip to main content

Natural anti-inflammatory compounds for the management and adjuvant therapy of inflammatory bowel disease and its drug delivery system

Archives of Pharmacal Research volume 32, pages 997–1004 (2009)Cite this article

Abstract

This project aims to investigate the anti-inflammatory properties of mastic [(Pistacia lentiscus var. Chia (Anacardiaceae)] extracted from the Chios mastic plant to help reduce intestinal inflammation in inflammatory bowel disease patients. Mastic and mastic resin were obtained from the Chios Mastiha Growers Association (www.mastihashop.com). The resin was ground into a fine powder using a pestle and mortar and formulated in factorial design manner. Evaluation of the efficacy of specific anti-inflammatory/antioxidant compounds in mitigating the clinical colitis parameters in a mouse model of colitis were performed with mastic itself and combination of tocopherol compounds. Colonic drug delivery system was developed consisting of two compartment model and its release profile was also investigated.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

39,95 €

Price includes VAT (Finland)

References

  • Al-Said, M. S., Ageel, A. M., Parmar, N. S., Tariq, M., Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J. Ethnopharmacol., 53(20), 15, 271–287 (1986).

    Google Scholar 

  • Ardizzone S. and Bianchi Porro G., Biologic therapy for inflammatory bowel disease. Drugs., 65(16), 2253–2286 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Brown, S. J. and Mayer, L., The immune response in inflammatory bowel disease. Am. J. Gastroenteril., 102(9), 2058–2069 (2007).

    Article  CAS  Google Scholar 

  • Chourasia, M. K. and Jain, S. K., Pharmaceutical approaches to colon targeted drug delivery system. J. Pharm. Pharm. Sci., 6(1), 33–66 (2003).

    PubMed  CAS  Google Scholar 

  • Dedoussis, G. V., Kaliora A. C., Psarras, S., Chiou, A., Mylona, A., Papadopoulos, N. G., and Andrikopoulos, N. K., Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis., 174, 293–303 (2004).

    PubMed  CAS  Google Scholar 

  • Fish, M. and Kugathasan, S., Inflammatory bowel disease. Adolesc Med Clin., 15(1), 67–90 (2004).

    Article  PubMed  Google Scholar 

  • Friend, D. R., New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug. Deliv. Rev., 57(2), 247–265 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Haddish-Berhane N., Farhadi., A., Nyquist, C., Haghighi, K., and Keshavarzian, A., Biological variability and targeted delivery of therapeutics for inflammatory bowel disease: an silico approach. Inflamm. Allergy Drug Targets., 6(1), 47–55 (2007).

    Article  Google Scholar 

  • Huwez F. U., Thirlwell, D., Cockayne, A., and Ala’Aldeen, D. A., Mastic gum kills Helicobacter pylori. N. Engl. J. Med., 339, 1946 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Jarnerot, G., Future aspects on inflammatory bowel disease. Scand. J. Gastroenterol. Suppl., 220, 87–90 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Koutsoudaki, C., Krsek, M., and Rodger, A., Chemical composition and antibacterial activity of the essential oil and the gum of Pistacia lentiscus Var. chia. J. Agric. Food Chem., 53(20), 7681–7685 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Loutrari, H., Magkouta, S. Pyriochou, A., Koika, V., Kolisis, F. N., Papapetropoulos, A., and Roussos, C., Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis. Nutr. Cancer, 55(1), 86–93 (2006).

    Article  Google Scholar 

  • Mutlu, E. A., Farhadi, A., and Keshavarzian, A., New developments in the treatment of inflammatory bowel disease. Expert Opin. Investig. Drugs., 11(3), 365–385 (2002).

    Google Scholar 

  • Onishi, H., Oosegi, T., and Machida, Y., Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzensulfonic acid-induced colitis. Int. J. Pharm., 358(1-2), 296–302 (2008).

    Article  Google Scholar 

  • Robinson, M., Medical therapy of inflammatory bowel disease for the 21st century. Eur. J. Surg. Suppl., 582, 90–98 (1998).

    Article  PubMed  Google Scholar 

  • Sandborn, W. J., What’s new: innovative concepts in inflammatory bowel disease. Colorectal. Dis., 15(1), Suppl 1:3–9 (2006).

    Article  Google Scholar 

  • Su, C. and Lichtenstein G. R., Recent developments in in-flammatory bowel disease. Med. Clin. North Am., 86(6), 1497–1523 (2002).

    Article  PubMed  Google Scholar 

  • Takaishi, H., Matsuki, T., Nakazawa, A., Takada, T., Kado, S., Asahara, T., Kamada, N., Sakuraba, A., Yajima, T., Higuchi, H., Inoue, N., Ogata, H., Iwao, Y., Nomoto, K., Tanaka, R., and Hibi, T., Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int. J. Med. Microbiol., 298(5–6), 463–472 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Targan S. R., Current limitations of IBD treatment: where do we go from here? Ann. N. Y. Acad. Sci., 1072, 1–8 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Van Assche, G., Vermeire, S., and Rutgeerts, P., Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapies. Gastroenterol. Clin. North Am., 35(4), 743–756 (2006).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jeil Pharmaceutical Co., Ltd., Youngin, 449-861, Korea

    Hyun-Jo Kim

  2. Yasoo Health Ltd., Nicosia, 1307, Cyprus

    Constantinos Neophytou

Authors
  1. Hyun-Jo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Constantinos Neophytou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyun-Jo Kim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kim, HJ., Neophytou, C. Natural anti-inflammatory compounds for the management and adjuvant therapy of inflammatory bowel disease and its drug delivery system. Arch. Pharm. Res. 32, 997–1004 (2009). https://doi.org/10.1007/s12272-009-1704-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-009-1704-1

Key words

  • Mastic oil
  • Inflammatory Bowel Disease (IBD)
  • Crohn Disease (CD)
  • Drug Delivery System (DDS)
  • Colon targeting
  • pH dependent polymer